• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA1/BRCA2 突变携带者的降低风险手术:是否存在与选择相关的因素?

Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?

作者信息

Manoukian Siranoush, Alfieri Sara, Bianchi Elisabetta, Peissel Bernard, Azzollini Jacopo, Borreani Claudia

机构信息

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Clinical Psychlogy Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.

出版信息

Psychooncology. 2019 Sep;28(9):1871-1878. doi: 10.1002/pon.5166. Epub 2019 Jul 11.

DOI:10.1002/pon.5166
PMID:31264307
Abstract

OBJECTIVE

Female carriers of BRCA1/BRCA2 mutations (BRCAm) are at increased risk of developing breast and ovarian cancer. The main prevention options currently available consist in either clinical-radiological surveillance or risk-reducing surgery. This study investigated factors that might influence the choice of risk-reducing mastectomy (RRM) and/or salpingo-oophorectomy (RRSO) over surveillance in high-risk women.

METHODS

One hundred twenty-eight BRCAm women, 75 (58.60%) cancer affected (C-A) and 53 (41.40%) cancer-unaffected (C-UN), completed a baseline questionnaire concerning socio-demographic factors, personal medical history, cancer family history, and psychological dimensions. Preferences about prevention strategies were evaluated after 15 months. Multivariate logistic regression was used to analyse the relationship between these factors and the choice of RRSO or RRM in the whole cohort and the choice of surgery (RRM and/or RRSO) in C-A and C-UN women.

RESULTS

The analyses on the whole cohort highlighted factors associated with the choice of both RRM and RRSO ("cancer concern," "previous therapeutic mastectomy," and "number of cancer-affected family members"), but also a few specifically associated with either RRM (age) or RRSO ("health" and "energy" perception and "number of children"). Surgery was more likely to be chosen by C-A (76%) than C-UN women (34%). With the exception of "cancer concern," factors associated with the choice of surgery were different between C-A ("number of deaths for cancer in the family" and "feeling downhearted and blue") and C-UN ("number of children" and "health perception") women.

CONCLUSION

This study highlights potential drivers underlying the choice of preventive surgery, which should be considered when supporting the decision-making process in these women.

摘要

目的

携带BRCA1/BRCA2基因突变(BRCAm)的女性患乳腺癌和卵巢癌的风险增加。目前可用的主要预防方法包括临床放射学监测或降低风险的手术。本研究调查了可能影响高危女性选择降低风险的乳房切除术(RRM)和/或输卵管卵巢切除术(RRSO)而非监测的因素。

方法

128名携带BRCAm的女性,其中75名(58.60%)患有癌症(C-A),53名(41.40%)未患癌症(C-UN),完成了一份关于社会人口学因素、个人病史、癌症家族史和心理维度的基线问卷。15个月后评估对预防策略的偏好。采用多变量逻辑回归分析这些因素与整个队列中RRSO或RRM的选择以及C-A和C-UN女性手术(RRM和/或RRSO)选择之间的关系。

结果

对整个队列的分析突出了与RRM和RRSO选择相关的因素(“癌症担忧”、“既往治疗性乳房切除术”和“患癌家庭成员数量”),但也有一些因素分别与RRM(年龄)或RRSO(“健康”和“精力”感知以及“子女数量”)特别相关。C-A女性(76%)比C-UN女性(34%)更有可能选择手术。除了“癌症担忧”之外,C-A女性(“家族中因癌症死亡的人数”和“情绪低落忧郁”)和C-UN女性(“子女数量”和“健康感知”)中与手术选择相关的因素有所不同。

结论

本研究突出了预防性手术选择背后的潜在驱动因素,在支持这些女性的决策过程时应予以考虑。

相似文献

1
Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?BRCA1/BRCA2 突变携带者的降低风险手术:是否存在与选择相关的因素?
Psychooncology. 2019 Sep;28(9):1871-1878. doi: 10.1002/pon.5166. Epub 2019 Jul 11.
2
Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.BRCA1/2 基因突变携带者的监测和预防策略的成本效益分析。
Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
3
The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.个人癌症病史和家族癌症病史对降低风险的输卵管卵巢切除术接受率的影响。
Fam Cancer. 2015 Dec;14(4):539-44. doi: 10.1007/s10689-015-9827-7.
4
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.在一个由1499名BRCA1和BRCA2突变携带者组成的前瞻性队列中进行降低风险手术的应用。
Breast Cancer Res Treat. 2014 Nov;148(2):397-406. doi: 10.1007/s10549-014-3134-0. Epub 2014 Oct 14.
5
Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.韩国国家癌症中心女性 BRCA 突变携带者进行降低风险的输卵管卵巢切除术的情况:经验总结
J Cancer Res Clin Oncol. 2016 Jan;142(1):333-40. doi: 10.1007/s00432-015-2051-x. Epub 2015 Oct 5.
6
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.在一家大型城市综合性癌症中心,对携带致病性 BRCA1/2 变异的遗传性乳腺癌和卵巢癌综合征女性进行了筛查和降低风险建议的评估。
Breast Cancer Res Treat. 2024 Jul;206(2):261-272. doi: 10.1007/s10549-024-07283-0. Epub 2024 Apr 12.
7
Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.影响携带 BRCA 基因突变女性行预防性输卵管卵巢切除术决策的因素。
Fam Cancer. 2013 Dec;12(4):621-8. doi: 10.1007/s10689-013-9625-z.
8
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
9
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.BRCA1/2 基因突变携带者中绝经前降低风险的输卵管卵巢切除术与乳腺癌风险的关联:最大程度减少偏倚。
Eur J Cancer. 2020 Jun;132:53-60. doi: 10.1016/j.ejca.2020.03.009. Epub 2020 Apr 20.
10
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.BRCA1 和 BRCA2 种系致病性变异女性行预防性输卵管卵巢切除术与乳腺癌风险的相关性。
JAMA Oncol. 2021 Apr 1;7(4):585-592. doi: 10.1001/jamaoncol.2020.7995.

引用本文的文献

1
Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial.影响携带BRCA1/2致病变异的健康女性决策中角色偏好的因素:一项随机对照决策指导试验的亚分析
BMC Cancer. 2025 Jan 28;25(1):164. doi: 10.1186/s12885-025-13541-1.
2
Risk-management decision-making data from a community-based sample of racially diverse women at high risk of breast cancer: rationale, methods, and sample characteristics of the Daughter Sister Mother Project survey.基于社区的、种族多样的乳腺癌高风险女性样本的风险管理决策数据:女儿姐妹母亲项目调查的基本原理、方法和样本特征。
Breast Cancer Res. 2024 Jan 11;26(1):8. doi: 10.1186/s13058-023-01753-x.
3
Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance.
葡萄牙 BRCA 致病性/可能致病性变异携带者选择风险降低乳房切除术或强化乳房监测的队列研究的差异。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7529-7538. doi: 10.1007/s00432-023-04663-9. Epub 2023 Mar 27.
4
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review.遗传性乳腺癌和卵巢癌高危女性中与接受降低风险的输卵管卵巢切除术决策相关的因素:一项系统综述
Korean J Women Health Nurs. 2020 Dec 31;26(4):285-299. doi: 10.4069/kjwhn.2020.11.19. Epub 2020 Dec 9.
5
Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.含角鲨烯佐剂AddaVax的卵巢癌疫苗制剂可抑制小鼠上皮性卵巢癌的生长。
Clin Exp Vaccine Res. 2022 May;11(2):163-172. doi: 10.7774/cevr.2022.11.2.163. Epub 2022 May 31.
6
Physician attitudes and knowledge on prophylactic salpingectomy in perimenopausal patients.医生对围绝经期患者预防性输卵管切除术的态度和知识
Gynecol Oncol Rep. 2021 Jun 30;37:100824. doi: 10.1016/j.gore.2021.100824. eCollection 2021 Aug.
7
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.以色列无症状 BRCA1 和 BRCA2 突变携带者中降低风险的乳房切除术接受率的时间趋势。
Breast Cancer Res Treat. 2021 Jan;185(2):391-399. doi: 10.1007/s10549-020-05949-z. Epub 2020 Sep 30.
8
Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.CDH1基因携带者考虑或接受预防性全胃切除术的障碍与促进因素。
Fam Cancer. 2021 Apr;20(2):157-169. doi: 10.1007/s10689-020-00197-y. Epub 2020 Aug 5.